Dexamethasone and long-term survival in bacterial meningitis

Neurology

Volumn 79, Issue 22, 2012, Pages 2177-2179

  Fritz, Daan ^a   Brouwer, Matthijs C ^a   Van De Beek, Diederik ^a  

^a Center for Infection and Immunity Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PLACEBO;

AGE; ARTICLE; BACTERIAL MENINGITIS; CONTROLLED STUDY; FOLLOW UP; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 84871298475     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31827595f7     Document Type: Article

References (7)

1. Fitch MT, van de Beek D. Drug insight: steroids in CNS infectious diseases-new indications for an old therapy. Nat Clin Pract Neurol 2008;4:97-104.
2. BrouwerMC, McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010;(9):CD004405.
3. TörökME, Nguyen DB, Tran TH, et al. Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents. PLoS One 2011;6:e27821.
4. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-1556.
5. van de Beek D, Farrar JJ, de Gans J, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010;9:254-263.
6. Brouwer MC, Heckenberg SG, de Gans J, Spanjaard L, Reitsma JB, van de Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010;75:1533-1539.
7. Weisfelt M, Hoogman M, van de Beek D, de Gans J, Dreschler WA, Schmand BA. Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol 2006; 60:456-468.